• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Clovis Oncology Inc

+ Add to Watchlist


34.445 EUR 0.544 1.55%

As of 03:02:33 ET on 09/19/2014.

Snapshot for Clovis Oncology Inc (C6O)

Open: 34.335 Day's Range: 34.335 - 34.445 Volume: 100
Previous Close: 34.989 52wk Range: 26.340 - 66.162 1-Yr Rtn: -36.11%

Stock Chart for C6O

No chart data available.
  • C6O:GR 34.445
  • 1D
  • 1M
  • 1Y
Interactive C6O Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for C6O

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -3.9950
Est. PEG Ratio -
Market Cap (M EUR) 1,169.89
Shares Outstanding (M) 33.96
30 Day Average Volume 322
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for C6O

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for C6O

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.

Patrick J MahaffyPresident/CEO/Co-FounderErle T MastExec VP/CFO/Secy/Co-Founder
Gillian C Ivers-ReadExec VP/Chief Regulatory OfcrAndrew R AllenExec VP/Chief Medical Ofcr
More Company Profile & Key Executives for C6O

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil